THE ROLE AND IMPORTANCE OF DIETOTHERAPY IN HEART DISEASES

Authors
  • Bekmuradova Makhsuda Salkhidinovna

    PhD, assistant at the Department of Propaedeutics of Internal Diseases, Samarkand Medical University. Samarkand city. Uzbekistan
  • Bozorova Sevara Aktamovna

    Leading teacher at the technical school of public health named after Abu Ali Ibn Sina in Kattakurgan
  • Avazova Gulzoda Axtamovna

    Leading teacher at the technical school of public health named after Abu Ali Ibn Sina in Kattakurgan
Keywords:
Heart Disease, Dietotherapy, Mediterranean Diet, DASH Diet, Cardiovascular Risk Factors
Abstract

Heart disease is a major global health issue, where dietotherapy complements pharmacological and surgical treatments. This study examines the role of dietotherapy, specifically the Mediterranean and DASH diets, in managing cardiovascular conditions. These diets, high in omega-3 fatty acids and fiber, are associated with reduced risk factors and cardiovascular events. Despite evidence of their effectiveness, gaps persist in long-term outcomes, adherence variability, and interactions with other treatments. Using a comprehensive review of randomized controlled trials and meta-analyses, the study finds that these diets significantly lower LDL cholesterol, blood pressure, and incidence of myocardial infarction and stroke. These results highlight the need to integrate dietotherapy into clinical practice alongside conventional treatments. Future research should focus on long-term impacts, effectiveness across different populations, and interactions with medications to refine dietary guidelines and improve patient outcomes.

References

1. Akesson A., Weismayer C., Newby P.K., Wolk A. Combined effect of low-risk dietary and lifestyle behaviors in primary prevention of myocardial infarction in women. Arch. Intern. Med. 2007;167:2122–2127. doi: 10.1001/archinte.167.19.2122. [PubMed] [CrossRef] [Google Scholar]

2. Alisherovna K. M. et al. QUALITY OF LIFE IN THE PATHOLOGY OF THE CARDIOVASCULAR SYSTEM //World Bulletin of Public Health. – 2023. – Т. 25. – С. 35-40.

3. Arnett D.K., Blumenthal R.S., Albert M.A., Buroker A.B., Goldberger Z.D., Hahn E.J., Himmelfarb C.D., Khera A., Lloyd-Jones D., McEvoy J.W., et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:596–646. doi: 10.1161/CIR.0000000000000678. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

4. Astrup A., Bertram H.C., Bonjour J.P., de Groot L.C., de Oliveira Otto M.C., Feeney E.L., Garg M.L., Givens I., Kok F.J., Krauss R.M., et al. WHO draft guidelines on dietary saturated and trans fatty acids: Time for a new approach? BMJ. 2019;366:l4137. doi: 10.1136/bmj.l4137.

5. Bekmuradova M. S. Makhmudova Kh. D., Nazarov F. Yu. Diagnostic significance of brain natriuretic peptide in the detection of chronic heart failure //Scientific progress. – 2021. – Т. 2. – №. 1. – С. 810-814.

6. Bekmuradova M. S., Gafforov K. K., Yarmatov S. T. The value of brain natriuretic peptide determination in the diagnosis of chronic heart failure //Achievements in science and education. – 2020. – Т. 4. – С. 58.

7. Bekmuradova M. S., Kh G. K., Yarmatov S. T. Significance of the determination of brain natriuretic peptide in the process of diagnosing chronic heart failure //Achievements of science and education. – 2020. – №. 4. – С. 58.

8. Gómez G., Kovalskys I., Leme A.C.B., Quesada D., Rigotti A., Cortés Sanabria L.Y., Yépez García M.C., Liria-Domínguez M.R., Herrera-Cuenca M., Fisberg R.M., et al. Socioeconomic Status Impact on Diet Quality and Body Mass Index in Eight Latin American Countries: ELANS Study Results. Nutrients. 2021;13:2404. doi: 10.3390/nu13072404.

9. Grosso G., Laudisio D., Frias-Toral E., Barrea L., Muscogiuri G., Savastano S., Colao A. Anti-Inflammatory Nutrients and Obesity-Associated Metabolic-Inflammation: State of the Art and Future Direction. Nutrients. 2022;14:1137. doi: 10.3390/nu14061137.

10. Kahleova H., Levin S., Barnard N.D. Vegetarian Dietary Patterns and Cardiovascular Disease. Prog. Cardiovasc. Dis. 2018;61:54–61. doi: 10.1016/j.pcad.2018.05.002. [PubMed] [CrossRef] [Google Scholar]

11. Kobylińska M., Antosik K., Decyk A., Kurowska K. Malnutrition in Obesity: Is It Possible? Obes. Facts. 2022;15:19–25. doi: 10.1159/000519503.

12. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:442. doi: 10.1371/journal.pmed.0030442.

13. Nazarov F. Y., Bekmuradova M. S. RESEARCH OF LOCAL CONTRACTABILITY OF THE MYOCARDIAL WITH THE HELP OF TISSUE DOPPLERA STREETS SUFFERING WITH DILATED CARDIOMYOPATHY //Galaxy International Interdisciplinary Research Journal. – 2022. – Т. 10. – №. 1. – С. 317-319.

14. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Kavouras S., Stefanadis C. The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: The ATTICA Study. Prev. Med. 2005;40:432–437. doi: 10.1016/j.ypmed.2004.07.010.

15. Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update from the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010.

16. Salkhidinovna B. M., Abrorovna V. N. The Relationship Between Elevated Pulse Pressure and Natriuretic Peptide //Miasto Przyszłości. – 2022. – Т. 25. – С. 119-121.

17. Tousoulis D., Oikonomou E., Economou E.K., Crea F., Kaski J.C. Inflammatory cytokines in atherosclerosis: Current therapeutic approaches. Eur. Heart J. 2016;37:1723–1732. doi: 10.1093/eurheartj/ehv759. [PubMed] [CrossRef] [Google Scholar]

18. Vafoeva N. A., Bekmuradova M. S. Important Aspects of the Treatment of Chronic Heart Failure. – 2022.

19. World Health Organization . Global Status Report on Noncommunicable Diseases. World Health Organization; Geneva, Switzerland: 2014. (No. WHO/NMH/NVI/15.1)

20. Yarmukhamedova S. et al. Study of indicators of intracardial hemodynamics and structural state of the myocardium in monotherapy of patients with arterial hypertension with moxonidin //Journal of Advanced Medical and Dental Sciences Research. – 2020. – Т. 8. – №. 9. – С. 78-81.

21. Yarmukhamedova S. K., Bekmuradova M. S. Level of sodiumuretic peptide in early diagnosis of chronic heart failure in patients with arterial hypertension. – 2021.

22. Yarmukhamedova S. K., Bekmuradova M. S. The development of heart failure in patients with essential hypertension in terms of natriuretic peptide //Eurasian Journal of Cardiology S. – 2019. – Т. 1. – С. 283-284.

23. Yarmukhamedova S. K., Bekmuradova M. S., Nazarov F. Y. Diagnostic value of natriuretic peptide in identifying patients with asymptomatic systolic or diastolic dysfunction //Achievements of science and education. – 2020. – Т. 8. – №. 62. – С. 84-88.

24. Бекмурадова М. С., Гаффоров Х. Х., Ярматов С. Т. Значение определения мозгового натрийуретического пептида в процессе диагностики хронической сердечной недостаточности //Достижения науки и образования. – 2020. – №. 4 (58). – С. 75-78.

25. Бекмурадова М. С., Махмудова Х. Д., Назаров Ф. Ю. ДИАГНОСТИЧЕСКАЯ ЗНАЧИМОСТЬ МОЗГОВОГО НАТРИЙУРЕТИЧЕСКОГО ПЕПТИДА ПРИ ВЫЯВЛЕНИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ //Scientific progress. – 2021. – Т. 2. – №. 1. – С. 810-814.

26. Бекмурадова М. С., Хайдаров С. Н. Связь между повышенным пульсовым давлением и натрийуретическим пептидом //Journal of cardiorespiratory research. – 2022. – Т. 3. – №. 1. – С. 26-29.

27. Ярмухамедова С. Х., Бекмурадова М. С. Развитие сердечной недостаточности у больных с гипертонической болезнью по показателям натрийуретического пептида //Евразийский кардиологический журнал. – 2019. – №. S1. – С. 283-284.

28. Ярмухамедова С. Х., Бекмурадова М. С., Назаров Ф. Ю. Диагностическая ценность натрийуретического пептида при выявлении пациентов с бессимптомной систолической или диастолической дисфункцией //Достижения науки и образования. – 2020. – №. 8 (62). – С. 84-88.

29. Ярмухамедова С. Х., Бекмурадова М. С., Назаров Ф. Ю. Значение уровня мозгового натрийуретического пептида в ранней диагностике хронической сердечной недостаточности у больных с артериальной гипертонией //Достижения науки и образования. – 2020. – №. 4 (58). – С. 61-63.